Funding Received
$38 Million in 1 Round from 1 Investor
Most Recent Funding
$38 Million Series A on March 25, 2013
Founded:
2012
Headquarters:
London
Description:
infirst Healthcare is a consumer healthcare company focused on improving well established drugs with IP-protected solutions.
Categories:
Health and Wellness
Website:
http://www.infirst.co.uk/

Detailed Description

Update

infirst HEALTHCARE is a new consumer healthcare company focused on improving well established drugs with IP protected solutions for the OTC/Primary care markets which can be launched within 12-36 months. infirst is a spin-out from SEEK, a UK privately-owned drug discovery group which uses its intellectual property to create breakthrough medicines addressing major diseases, bringing radical improvements to human health.

infirst is led by CEO, Manfred Scheske, who was previously President of GSK's US$3 billion European Consumer Healthcare business (including brands such as alli, Aquafresh, Beechams, Corsodyl, Lucozade, Niquitin, Panadol. Piriton, Poligrip, Ribena, Sensodyne, Solpadeine, Zantac and Zovirax) from 2004 to 2010 and also spent six years as President of GSK's Consumer Healthcare business in North America

Current Team (1)

Update

Funding Rounds (1) - $38M

Update

Investors (1)

Update
  • 67ba4c4605311245d7bf54114025a283

    Invesco Asset Management

    Great ideas transcend borders. With more than 740 dedicated investment professionals worldwide...

Offices/Locations (1)

Update
  • Office

    100 Fetter Lane

    London, EC4A 1BN

    GBR